Antimicrobial Stewardship Centers of Excellence

In 2021, bioMérieux established these partnerships to bring attention to the threat of antimicrobial resistance and to accelerate the impact that infectious disease diagnostics have in facilitating antimicrobial stewardship. bioMérieux has formalized partnerships with 15 hospitals globally, including sites in Canada, Chile, China, Colombia, France, Germany, India, Italy, Kenya, Malaysia, Mexico, Morocco, and the United States. These sites are leaders in their countries and regions regarding integrating diagnostics into antimicrobial stewardship. The partnerships will focus on generating and showcasing real-world medical and economic data and best practices about the value of combining diagnostics, advanced analytics, consultancy services, and educational resources.

• Complete end-to-end diagnostics solution to guide clinical decision-making
• Leaders in diagnostics and AMS in their country and/or region
• Engagement in research and evidence generation about the value of diagnostic tools and their role in combating AMR
• Openness to continuous process improvement

This designation signifies these hospitals and laboratories as partners of choice for bioMérieux to further define and demonstrate data-driven best practices, to improve interventions, and identify new diagnostic solutions in combatting AMR.

Each Center of Excellence healthcare system is presented with an AMS Centers of Excellence seal that symbolizes the joint commitment, trust, and vision of the partnership.

Highlights from the latest advancements and news about the AMS Centers of Excellence initiatives, which are driving transformative solutions in AMS. bioMérieux AMS COE partners are making strides in AMS, demonstrating value, and improving patient care in their hospitals and health systems.